1Sharma T.Cognitive effects of conventional and atypical antipsychotics in schizophrenia[].British Journal of Psychiatry.1999
2Braver TS,Barch DM,Cohen JD.Cognition and control in schizophrenia: accomputational model of dopamine and prefrontal function[].Biological Psychiatry.1999
3Horton R,Katona C.Biological aspects of affective disorder[]..1991
4Carlsson A,Hansson LO,Waters N,et al.A glutamatergic deficiency model of schizophrenia[].British Journal of Psychiatry.1999
5Fuxe K,Rambert FA,Ferraro L,et al.Preclinical study with modafinal: Evidence for vigilance enhancement and neuroprotein[].Drugs of Today.1996
6Arendt J,Minors DS,Waterhouse JM.Biological rhythms in clinical practive[]..1989
7Nutt D.Alcohol and the brain[].British Journal of Psychiatry.1999
8Lieberman JA,Mailman RB,Duncan G,et al.Serotonergic basis of antipsychotic drug effects in schizophrenia[].Biolpsychiatry.1998
9Tamminga C.Glutamatergic aspects of schizophrenia[].British Journal of Psychiatry.1999
10Csillik-Perczel V,Bakonyi A,Yemane T,et al.GYK-46903, a noncompetitive antagonist for 5-HT3 receptors[].Pharmacology and Toxicology.1996
